Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 941–960 of 1,000 recalls
HARDCORE FORMULATIONS
Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine.
Vitility
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.